Breast Cancer Coverage from Every Angle
Advertisement
Advertisement

Sara A. Hurvitz, MD, on Ribociclib Plus Endocrine Therapy for Premenopausal Women With Advanced Breast Cancer

Posted: Wednesday, July 3, 2019

Sara A. Hurvitz, MD, of the UCLA Jonsson Comprehensive Cancer Center, discusses the implications of the MONALEESA-7 trial for premenopausal women and how clinicians can address their patients’ concerns about altered hormonal status.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.